D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

BCAX holding history

Bicara Therapeutics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCAX overview All 13F holders of BCAX Full Q2 2026 holdings

Shares (Q2 2026): 498,193
Value: $14.8M
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of BCAX by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	498,193	$14.8M	<0.1%	+221,250+79.9%	Added	Holders
Q1 2026	276,943	$5.51M	<0.1%	+140,421+102.9%	Added	Holders
Q4 2025	136,522	$2.30M	<0.1%	+136,522	New	Holders